Concepedia

Eva Martinez‐Balibrea

EM

22

Publications

1.2K

Citations

17

H-Index

2003

Active since

Affiliations

Institut Català d'Oncologia(Current)

Hospital Universitari Germans Trias i Pujol

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Institut d'Investigació Biomédica de Bellvitge

Universitat de Barcelona

Eva Martinez‐Balibrea is an author at Institut Català d'Oncologia specializing in oncology, medicine, and colorectal cancer.

ORCID

Top concepts

Publications per year

2003–2025

22

Publications

22

Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway

Vicenç Ruiz de Porras, Sara Bystrup, Anna Martínez‐Cardús et al. · Scientific Reports · 2016 · 131 citations · Full text

A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect

Paula López-Serra, Miguel Marcilla, Alberto Villanueva et al. · Nature Communications · 2014 · 113 citations · Full text

Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer

Cátia Moutinho, Anna Martínez‐Cardús, Cristina Santos et al. · JNCI Journal of the National Cancer Institute · 2013 · 96 citations · Full text

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

Eva Martinez‐Balibrea, Albert Abad, Anna Martínez‐Cardús et al. · British Journal of Cancer · 2010 · 88 citations · Full text

, , +8

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

Jordi Codony‐Servat, Míriam Cuatrecasas, Elena Asensio et al. · British Journal of Cancer · 2017 · 76 citations · Full text

Rows per page

1–5 of 22